SCHEMBL6944935

SCHEMBL6944935

CCc1ccccc1N/C=C1/C(=O)N(c2ccc(NC(=O)OC)cc2)N=C1CC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 4/20 0.43
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
PKM P14618 1/20 0.36
PTGDR2 Q9Y5Y4 5/20 0.36
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KAT8 Q9H7Z6 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944940 1.00 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6952731 0.93 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6952727 0.93 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6952770 0.91 MAPT (0.41) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6952774 0.91 MAPT (0.41) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6946840 0.90 MEN1 (0.49) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6946842 0.90 MEN1 (0.49) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL8008609 0.89 KMT2A (0.37) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL8008612 0.89 KMT2A (0.37) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL6952803 0.87 TP53 (0.39) ALDH1A1MEN1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed